The global isocitrate dehydrogenase (IDH) inhibitors market is poised for extraordinary growth, with a market value of USD 2.26 billion in 2023 projected to surge to a staggering USD 39.16 billion by 2033, marking a robust compound annual growth rate (CAGR) of 33% over the forecast period. Additionally, the development of more potent and selective …
Tag Archives: Isocitrate Dehydrogenase (IDH) Inhibitors Market
Isocitrate Dehydrogenase (IDH) Inhibitors Market Secures Remarkable Valuation of US$39.16 Billion in 2033
The isotrate dehydrogenase (IDH) inhibitors market sales is predicted to expand from US$ 1.7 billion in 2022 to US$ 39.16 billion in 2033, with a compound annual growth rate (CAGR) of 33% from 2023 to 2033. Additionally, the development of more potent and selective IDH inhibitors, as well as the expansion of their use into …
Isocitrate Dehydrogenase (IDH) Inhibitors Market Secures a Remarkable Valuation of US$39.16 Billion in 2033-FMI Study
Isocitrate dehydrogenase (IDH) inhibitors market size are expected to reach US$ 39.16 billion in 2033, growing at a compound annual growth rate (CAGR) of 33% from 2023 to 2033, from a market size of US$ 1.7 billion in 2022. Additionally, the development of more potent and selective IDH inhibitors, as well as the expansion …